Xylem (XYL) Liabilities and Shareholders Equity (2010 - 2026)

Xylem's Liabilities and Shareholders Equity history runs 17 years deep, the most recent figure standing at $17.0 billion for Q1 2026.

• On a quarterly basis, Liabilities and Shareholders Equity rose 2.39% year-over-year to $17.0 billion in Q1 2026; TTM through Mar 2026 was $69.1 billion, a 6.49% increase from a year earlier, with the FY2025 full-year figure at $17.6 billion, up 6.92% from the prior year.
• Liabilities and Shareholders Equity declined to $17.0 billion in Q1 2026 per XYL's latest filing, from $17.6 billion in the prior quarter.
• Across five years, Liabilities and Shareholders Equity topped out at $17.6 billion in Q4 2025 and bottomed at $7.9 billion in Q1 2023.
• The 5-year median for Liabilities and Shareholders Equity is $16.0 billion (2024), against an average of $14.0 billion.
• Across the five-year window, Liabilities and Shareholders Equity decreased 6.78% in 2022 and soared 102.62% in 2023, its largest moves.
• Year by year, Liabilities and Shareholders Equity stood at $8.0 billion in 2022, then soared by 102.62% to $16.1 billion in 2023, then grew by 2.36% to $16.5 billion in 2024, then increased by 6.92% to $17.6 billion in 2025, then fell by 3.86% to $17.0 billion in 2026.
• Per Business Quant, the three latest XYL Liabilities and Shareholders Equity figures stand at $17.0 billion (Q1 2026), $17.6 billion (Q4 2025), and $17.3 billion (Q3 2025).